O
32.02
-0.25 (-0.77%)
| Previous Close | 32.27 |
| Open | 31.92 |
| Volume | 1,835,221 |
| Avg. Volume (3M) | 1,910,554 |
| Market Cap | 5,259,092,992 |
| Price / Earnings (TTM) | 26.03 |
| Price / Earnings (Forward) | 19.23 |
| Price / Sales | 0.900 |
| Price / Book | 3.42 |
| 52 Weeks Range | |
| Earnings Date | 29 Apr 2025 |
| Profit Margin | 4.12% |
| Operating Margin (TTM) | 5.94% |
| Diluted EPS (TTM) | 1.25 |
| Quarterly Revenue Growth (YOY) | 16.30% |
| Quarterly Earnings Growth (YOY) | 4.40% |
| Total Debt/Equity (MRQ) | 90.53% |
| Current Ratio (MRQ) | 1.54 |
| Operating Cash Flow (TTM) | 384.96 M |
| Levered Free Cash Flow (TTM) | 294.46 M |
| Return on Assets (TTM) | 6.33% |
| Return on Equity (TTM) | 15.38% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Bearish |
| Medical Care Facilities (Global) | Mixed | Bearish | |
| Stock | Option Care Health, Inc. | Mixed | Bearish |
AIStockmoo Score
0.6
| Analyst Consensus | 0.5 |
| Insider Activity | 2.5 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | 0.60 |
|
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 0.69% |
| % Held by Institutions | 103.96% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 38.00 (JMP Securities, 18.68%) | Buy |
| 38.00 (Barrington Research, 18.68%) | Buy | |
| Median | 38.00 (18.68%) | |
| Average | 38.00 (18.68%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 29.92 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JMP Securities | 31 Jul 2025 | 38.00 (18.68%) | Buy | 29.35 |
| 18 Jun 2025 | 36.00 (12.43%) | Buy | 31.56 | |
| Barrington Research | 10 Jul 2025 | 38.00 (18.68%) | Buy | 30.49 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| GOLDING DAVID W | 27.84 | - | 1,000 | 27,840 |
| SULLIVAN TIMOTHY P | 27.84 | - | 20,000 | 556,800 |
| Aggregate Net Quantity | 21,000 | |||
| Aggregate Net Value ($) | 584,640 | |||
| Aggregate Avg. Buy ($) | 27.84 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| GOLDING DAVID W | Director | 21 Aug 2025 | Buy (+) | 1,000 | 27.84 | 27,840 |
| SULLIVAN TIMOTHY P | Director | 21 Aug 2025 | Buy (+) | 20,000 | 27.84 | 556,800 |
| Date | Type | Details |
|---|---|---|
| 25 Aug 2025 | Announcement | Option Care Health To Participate in Upcoming Investor Conferences |
| 20 Aug 2025 | Announcement | Option Care Health Announces Chief Financial Officer Transition |
| 07 Aug 2025 | Announcement | Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP |
| 30 Jul 2025 | Announcement | Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025 |
| 25 Jun 2025 | Announcement | Option Care Health to Announce Second Quarter 2025 Financial Results and Host Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |